Atlas Trials

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Clinical trial NCT01646255 · COMPLETED

Trial details

NCT number
NCT01646255
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Parkinson's Disease
Start date
2012-07-01
Primary completion
2014-10-01
Enrollment
346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.